2007 Press Releases

October 15, 2007 - Phenomix Hires John Crawford As Chief Financial Officer and Appoints Arlene Morris to Board of Directors

September 11, 2007 - Phenomix Initiates Phase 2b Clinical Trial Of PHX1149 For Type 2 Diabetes; Will Present PHX1149 Data At EASD

July 19, 2007 - Phenomix Appoints James Harper and William Harris to Board of Directors

March 8, 2007 - Phenomix Completes $55 Million Series C Financing

March 5, 2007 - Phenomix Completes Phase 2A Clinical Trial Diabetes Drug Is Efficacious And Well Tolerated

2006 Press Releases

June 8, 2006 - Phenomix Initiates Phase II Clinical Trial Of PHX1149 For Type 2 Diabetes And Presents PHX1149 Data At ADA

May 10, 2006 - Phenomix Appoints David Gryska to Board of Directors

2005 Press Releases

June 10, 2005 - Phenomix' Scientific Founder, Christopher Goodnow, Awarded Prestigious Award From Australian Government

May 24, 2005 - Phenomix Closes Series B Financing At $40 Million

2004 Press Releases

August 25, 2004 - Phenomix Appoints Hans-Peter Guler, M.D. Vice President Of Clinical Development

2003 Press Releases

November 13, 2003 - Phenomix Appoints Julie Cherrrington, Ph.D. As President Of Australian Operations

October 14, 2003 - Phenomix Investors Increase Financial Commitment To $35.5 Million

May 29, 2003 - Phenomix Expands Executive Leadership Team

Mar 18, 2003 - Renowned Immunology Experts Christophe Benoist &a,p; Diane Mathis Bolster Scientific Advisory Board

2002 Press Releases

Oct 28, 2002 - Phenomix Appoints Drs. Stephen Fodor & John Todd to Scientific Advisory Board

Jun 18, 2002 - Phenomix Corporation Appoints Laura Shawver as President and CEO

Mar 11, 2002 - Phenomix Accesses $32 Million in Over-Subscribed Series A Investment Round